Les complications infectieuses liées à l’utilisation des anticorps monoclonaux chez l’homme
Author:
Publisher
EDP Sciences
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
http://www.medecinesciences.org/10.1051/medsci/200925121135/pdf
Reference32 articles.
1. Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy.Nature1988; 332 : 323–7.
2. Nückel H, Frey UH, Röth A, Dührsen U, Siffert W. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.Eur J Pharmacol2005; 514 : 217–24.
3. Osterborg A, Dyer MJ, Bunjes D,et al.Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.J Clin Oncol1997; 15 : 1567–74.
4. Rai KR, Freter CE, Mercier RJ,et al.Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.J Clin Oncol2002; 20 : 3891–7.
5. Keating MJ, Flinn I, Jain V,et al.Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.Blood2002; 99 : 3554–61.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk of tuberculosis in patients treated with biological medicines;Bratislava Medical Journal;2016
2. Complications infectieuses des anticorps thérapeutiques;La Revue de Médecine Interne;2015-12
3. Actualités sur l’immunothérapie anti-cytokine par les vaccins kinoïdes dans le traitement des maladies inflammatoires;médecine/sciences;2013-06
4. The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy;Clinical Microbiology and Infection;2011-12
5. Two cases of opportunistic parasite infections in patients receiving alemtuzumab;Journal of Clinical Pathology;2011-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3